Prof. Anne Lee is the Clinical Professor of the Department of Clinical Oncology, the University of Hong Kong. She has served as the Department Head from 2015 to 2021. She has been endowed as Alice Ho Miu Ling Nethersole Charity Foundation Professor in Holistic Cancer Care. She is the Chief of Service for the Center of Clinical Oncology at the University of Hong Kong-Shenzhen Hospital in China; furthermore, she has taken up administration as the Deputy Hospital Chief Executive (Clinical Service,  Education & Training). She is Honorary Professor of Peking Union Medical College Hospital and External Supervisor for Tsinghua Shenzhen International Graduate School in China. Besides serving as the Deputy Chief of Service and Honorary Consultant for the Department of Clinical Oncology at Queen Mary Hospital, Hong Kong, she is also an Honorary Consultant for Hong Kong Sanatorium & Hospital, as well as Gleneagles Hong Kong Hospital.

Prof. Lee's main research contributions focus on nasopharyngeal cancer and precision oncology. She is currently the Chairman of Hong Kong Nasopharyngeal Cancer Study Group, Vice-Chairman of the National Cancer Staging Committee of China, and Honorary Chairman for the Precision Treatment of Nasopharyngeal Cancer Sub-Committee, under the Clinical Medicine Committee of Guangdong Province. Prof. Lee is a dedicated advocate for cancer control, she serves as Board of Directors for the Union for International Cancer Control, and she is the Coordinator of UICC TNM Global Advisory Group. She is the Vice Chairman of Hong Kong Anti-Cancer Society. She serves many editorial boards, and is currently a Senior Editor (Clinical) for Radiotherapy and Oncology.

Prof. Lee has received many international honors/awards for our outstanding researches on nasopharyngeal cancer, including Gilbert H. Fletcher Distinguished Professor Lecturer by The University of Texas, M.D. Anderson Cancer Center, United States in 2009; Honorary Membership by the European Society for Radiotherapy & Oncology in 2012; Honorary Membership by the Radiological Society of North America in 2013; Wharton Lecturer by Princess Margaret Cancer Centre, Canada in 2015; and Honorary Fellowship by American College of Radiology in 2019. In China, she has been awarded First Prize of Science and Technology Award by Fujian Government in 2018 and First Prize of Technology Award by Fujian Anti-Cancer Association in 2021. In addition, she has received many awards for hospital administration, including Good Doctor in Shenzhen by Health and Family Planning commission of Shenzhen Municipality in 2018; Outstanding Contribution by Health News, Bureau of Medical Administration, National Health Commission in 2019; Excellent Medical Personnel of Shenzhen Municipality by Shenzhen Municipal Health Commission in 2020.